Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer
Clinical trial NCT01350817 · COMPLETED
Trial details
- NCT number
- NCT01350817
- Sponsor
- University Hospital, Limoges
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-03-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.